Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms RSS Feed RSS Feeds RSS Feed PharmiWeb Candidate Blog RSS Feed PharmiWeb Client Blog


Press Release

Global Drugs & Diagnostics for Hematological Disorders Market Worth USD 124.3 Billion by 2020 - Analysis, Technologies & Forecasts Report 2016-2020 - Key Vendors: Biogen, Genmab, Gilead Sciences - Research and Markets

Research and Markets
Posted on: 30 Sep 16

Research and Markets has announced the addition of the "Drugs and Diagnostics for Hematological Disorders: Global Markets" report to their offering.

The global market for hematology drugs and diagnostics is expected to grow from nearly $86.5 billion in 2015 to $124.3 billion in 2020 at a compound annual growth rate of 7.5% from 2015-2020.

This report provides:

  • An overview of the global market for drugs and diagnostics for hematological disorders.
  • Analyses of global market trends, with data from2015, and projections of CAGRs through 2020.
  • A breakdown of the market by hematological diseases, hematological cancers, and hematological diagnostics.
  • A review of blood cancers, such as various types of leukemia, lymphoma, and myeloma, and their therapies.
  • Evaluation of the market's dynamics, specifically growth drivers, restraints, and opportunities
  • Delineation of drugs approved by the FDA for hematological disorders.
  • Profiles of key companies in the industry.

The report also discusses the regulatory environment, current technologies, new technologies, hematological disorders and cancer incidence, market projections and market share, along with latest trends, and clinical and new developments.

Companies Mentioned Include:

  • Abbott Laboratories
  • Abon Pharmaceuticals
  • Ambit Biosciences
  • Amgen
  • Amphastar Pharmaceuticals
  • Ariad Pharmaceuticals
  • Astellas Pharma Us
  • Astex Pharmaceuticals
  • Astrazeneca
  • Baxalta Inc.
  • Baxter Healthcare Corp.
  • Bayer Healthcare Pharmaceuticals
  • Biogen Idec
  • Daiichi Sankyo Co. Ltd.
  • Deciphera Pharmaceuticals
  • Diagnocure
  • Eisai Inc.
  • ELI Lilly And Co.
  • Enzon Pharmaceuticals
  • Erytech Pharma Sa
  • Exelixis
  • GE Healthcare
  • Genentech Inc.
  • Genmab Inc.
  • Gilead Sciences

Report Structure:

1: Introduction

2: Summary

3: Hematalogical Disorders

4: Hematological Cancers

5: Leukemia

6: Lymphoma

7: Multiple Myeloma

8: Myelodysplastic Syndromes

9: Myeloproliferative Disorders

10: Epidemiology Of Hematological Cancers

11: Hematology Instruments And Reagents: A Global Market Perspective

12: Global Market For Treatments For Hematological Disorders

13: Hematological Cancer Therapies Market

14: Patent Landscape And Current Developments

15: Selected Company Profiles

16: Bibliography

For more information about this report visit

View source version on

Business Wire

Last updated on: 30/09/2016

Share | | |
Site Map | Privacy & Security | Cookies | Terms and Conditions is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.